TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,388
|
1,274
|
1,001 |
Financial expenses |
96
|
1
![]() |
1 |
Earnings before taxes |
158
|
487
|
599 |
EBITDA |
204
|
300
|
-62 |
Total assets |
1,323
|
1,951
|
1,650 |
Current assets |
585
|
1,375
|
1,173 |
Current liabilities |
424
|
993
|
621 |
Equity capital |
427
|
612
|
809 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
31.4%
|
49.0% |
Turnover per employee |
1,388
|
1,274
|
1,001 |
Profit as a percentage of turnover |
11.4%
|
38.2%
|
59.8% |
Return on assets (ROA) |
19.2%
|
25.0%
|
36.4% |
Current ratio |
138.0%
|
138.5%
|
188.9% |
Return on equity (ROE) |
37.0%
|
79.6%
|
74.0% |
Change turnover |
23
|
304
|
-87 |
Change turnover % |
2%
|
31%
|
-8% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.